85 related articles for article (PubMed ID: 23060564)
1. Synergism in concomitant chemoradiotherapy of cisplatin and oxaliplatin and their liposomal formulation in the human colorectal cancer HCT116 model.
Tippayamontri T; Kotb R; Paquette B; Sanche L
Anticancer Res; 2012 Oct; 32(10):4395-404. PubMed ID: 23060564
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of cisplatin and Lipoplatin™ in combined treatment with radiation of a colorectal tumor in nude mouse.
Tippayamontri T; Kotb R; Paquette B; Sanche L
Anticancer Res; 2013 Aug; 33(8):3005-14. PubMed ID: 23898053
[TBL] [Abstract][Full Text] [Related]
3. Cellular uptake and cytoplasm / DNA distribution of cisplatin and oxaliplatin and their liposomal formulation in human colorectal cancer cell HCT116.
Tippayamontri T; Kotb R; Paquette B; Sanche L
Invest New Drugs; 2011 Dec; 29(6):1321-7. PubMed ID: 20658169
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic possibilities of combined treatment of radiotherapy with oxaliplatin and its liposomal formulation, Lipoxal™, in rectal cancer using xenograft in nude mice.
Tippayamontri T; Kotb R; Sanche L; Paquette B
Anticancer Res; 2014 Oct; 34(10):5303-12. PubMed ID: 25275023
[TBL] [Abstract][Full Text] [Related]
5. Treatment schedule-dependent effect of 5-fluorouracil and platinum derivatives in colorectal cancer cells.
Takara K; Fujita M; Minegaki T; Yamamoto K; Takahashi M; Yokoyama T; Okumura K
Eur J Pharm Sci; 2012 Feb; 45(3):272-81. PubMed ID: 22155546
[TBL] [Abstract][Full Text] [Related]
6. Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain.
Charest G; Sanche L; Fortin D; Mathieu D; Paquette B
J Neurooncol; 2013 Dec; 115(3):365-73. PubMed ID: 24026531
[TBL] [Abstract][Full Text] [Related]
7. Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells.
Nessa MU; Beale P; Chan C; Yu JQ; Huq F
Anticancer Res; 2012 Jan; 32(1):53-9. PubMed ID: 22213288
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
Folkvord S; Flatmark K; Seierstad T; Røe K; Rasmussen H; Ree AH
Radiother Oncol; 2008 Mar; 86(3):428-34. PubMed ID: 18006097
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells.
Temmink OH; Hoebe EK; van der Born K; Ackland SP; Fukushima M; Peters GJ
Br J Cancer; 2007 Jan; 96(2):231-40. PubMed ID: 17242697
[TBL] [Abstract][Full Text] [Related]
10. Superior cytotoxicity and DNA cross-link induction by oxaliplatin versus cisplatin at lower cellular uptake in colorectal cancer cell lines.
Virag P; Perde-Schrepler M; Fischer-Fodor E; Tatomir C; Dorneanu SA; Cernea VI; Irimie A
Anticancer Drugs; 2012 Nov; 23(10):1032-8. PubMed ID: 22614106
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo.
Chen SJ; Kuo CC; Pan HY; Tsou TC; Yeh SC; Chang JY
Biochem Pharmacol; 2015 May; 95(1):28-37. PubMed ID: 25801007
[TBL] [Abstract][Full Text] [Related]
12. Concomitant Chemoradiation Therapy with Gold Nanoparticles and Platinum Drugs Co-Encapsulated in Liposomes.
Charest G; Tippayamontri T; Shi M; Wehbe M; Anantha M; Bally M; Sanche L
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32659905
[TBL] [Abstract][Full Text] [Related]
13. Synergism from the combination of oxaliplatin with selected phytochemicals in human ovarian cancer cell lines.
Yunos NM; Beale P; Yu JQ; Huq F
Anticancer Res; 2011 Dec; 31(12):4283-9. PubMed ID: 22199293
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.
Meynard D; Le Morvan V; Bonnet J; Robert J
Oncol Rep; 2007 May; 17(5):1213-21. PubMed ID: 17390068
[TBL] [Abstract][Full Text] [Related]
15. Convection-enhancement delivery of liposomal formulation of oxaliplatin shows less toxicity than oxaliplatin yet maintains a similar median survival time in F98 glioma-bearing rat model.
Shi M; Fortin D; Paquette B; Sanche L
Invest New Drugs; 2016 Jun; 34(3):269-76. PubMed ID: 26961906
[TBL] [Abstract][Full Text] [Related]
16. EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells.
Hu F; Wei F; Wang Y; Wu B; Fang Y; Xiong B
J Pharmacol Sci; 2015 May; 128(1):27-34. PubMed ID: 26003085
[TBL] [Abstract][Full Text] [Related]
17. Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer.
Yokoo S; Masuda S; Yonezawa A; Terada T; Katsura T; Inui K
Drug Metab Dispos; 2008 Nov; 36(11):2299-306. PubMed ID: 18710896
[TBL] [Abstract][Full Text] [Related]
18. Studies on combinations of platinum with paclitaxel and colchicine in ovarian cancer cell lines.
Yunos NM; Beale P; Yu JQ; Strain D; Huq F
Anticancer Res; 2010 Oct; 30(10):4025-37. PubMed ID: 21036717
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo enhancement of chemoradiation using the oral PARP inhibitor ABT-888 in colorectal cancer cells.
Shelton JW; Waxweiler TV; Landry J; Gao H; Xu Y; Wang L; El-Rayes B; Shu HK
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):469-76. PubMed ID: 23540347
[TBL] [Abstract][Full Text] [Related]
20. In vitro schedule-dependent interaction between melphalan and oxaliplatin in human colorectal cancer cell lines.
van Iersel LB; Koudijs TM; Hoekman EJ; Janssen-van Rhijn CM; Vahrmeijer AL; Nortier JW; van de Velde CJ; Gelderblom H; Kuppen PJ
J Surg Res; 2011 May; 167(2):273-8. PubMed ID: 20036390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
